The Tregs in p1_C27 highly expressed all tested markers and moderate levels of GITR, an immune checkpoint that was recently described to mark the most immune-suppressive Treg subset in NSCLC and associated with PD-1 resistance (21). The gene discussed is TNFRSF18; the disease is non-small cell lung carcinoma.